Trial Scorecard: SOUL
US$ 28.94
hers glp 1 injections Novo Nordisk Signs Deal with Hims & Hims & Hers Stock Plummets.
Description
B., & Klein, K
Development and validation of a new score to assess the risk of posttransplantation diabetes mellitus in kidney transplant recipients
In reality, individual tolerance varies widely some people breeze through titration, but according to a Blue Health Intelligence report almost all new users of GLP-1 drugs suffer from some gastrointestinal side effects (source)
doi: 10.1002/iub.2031
Evidence standard FormBlends does not claim an individual clinician byline unless a named reviewer is available
The tracker stays useful whoever prescribes the medication
